Litcius/Paper detail

Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews

Jingjing Yu, Yan Wang, Isabelle Ragueneau‐Majlessi

2024Clinical Therapeutics11 citationsDOI

Topics & Concepts

MedicineDrugPharmacologyFood and drug administrationTransporterBiochemistryChemistryGenePharmacogenetics and Drug MetabolismComputational Drug Discovery MethodsDrug Transport and Resistance Mechanisms
Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews | Litcius